passages.id: split_1_test_2285_passage
passages.type: progene_text
passages.text: Sales of oprelvekin were US $34 million for Genetics institute in fiscal 2000 while , in July 2001 , Credit Suisse First Boston estimated that this figure will be US $30 million and US $34 million in 2001 and 2002 , respectively [ 416883 ] .